NSPR – inspiremd inc. (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

NSPR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/26

09:00 am

nspr

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference

Medium Report

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference

Report

3/18

02:06 am

nspr

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Low Report

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Report

3/12

08:07 pm

nspr

InspireMD, Inc. (NSPR) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]

Low Report

InspireMD, Inc. (NSPR) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]

Report

3/12

02:04 pm

nspr

InspireMD, Inc. (NSPR) Q4 2024 Earnings Call Transcript [Seeking Alpha]

Low Report

InspireMD, Inc. (NSPR) Q4 2024 Earnings Call Transcript [Seeking Alpha]

Report

3/12

07:00 am

nspr

InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results

Low Report

InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results

Report

3/10

02:04 am

nspr

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Medium Report

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Report

3/2

02:06 am

nspr

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

High Report

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Report

3/2

02:06 am

nspr

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

High Report

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Report

2/26

08:00 am

nspr

InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results

Medium Report

InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results

Report

2/25

08:00 am

nspr

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

High Report

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Report

2/24

06:11 am

nspr

Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five years [Yahoo! Finance]

Medium Report

Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five years [Yahoo! Finance]

Report

2/22

02:07 am

nspr

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Medium Report

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Report

2/13

08:11 am

nspr

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures [Yahoo! Finance]

Medium Report

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures [Yahoo! Finance]

Report

2/13

07:00 am

nspr

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures

Low Report

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures

Report

2/6

03:35 am

nspr

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Medium Report

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Report

2/4

07:00 am

nspr

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Medium Report

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Report

1/29

02:00 am

nspr

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Medium Report

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Report

1/21

08:13 am

nspr

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]

Medium Report

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]

Report

1/21

07:00 am

nspr

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Medium Report

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Report

1/21

02:01 am

nspr

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Medium Report

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Report

1/13

02:10 am

nspr

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Medium Report

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Report

1/5

02:13 am

nspr

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Low Report

InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.